iOS 26.4 Adds Granular Hotspot Tracking
Apple's latest iOS 26.4 update introduces more detailed data tracking for its Personal Hotspot feature. Users can now see data usage on a per-device basis. The change reflects a broader trend toward providing users with more granular transparency and control over their device data.
- Prior to this update, iOS showed a single, cumulative data usage figure for Personal Hotspot, which could be found under Settings > Cellular > System Services. To track usage for a specific period, users had to manually reset these statistics at the beginning of each billing cycle. - This per-device tracking brings iOS closer to the functionality available on some Android devices, which have offered the ability to see a list of connected devices and their individual data usage for some time. - The move toward more detailed data transparency mirrors a broader trend in consumer health tech, where granular data from wearables and apps is used to provide personalized wellness recommendations and predictive health analytics. - For consumer health apps, building trust is a key growth factor, and leveraging privacy is seen as a marketing multiplier. New state-level health data privacy laws, like Washington's My Health My Data Act, are expanding beyond HIPAA to regulate consumer-generated health data from apps and wearables, requiring explicit opt-in consent for data collection and sharing. - Successful consumer health apps like Noom have leveraged a multi-faceted growth strategy that includes a strong affiliate and influencer marketing program, a personalized and adaptive user onboarding experience, and strategic partnerships with healthcare providers. The company is also positioning itself as a companion for users of GLP-1 medications. - For founders in the digital health space, especially those with a technical background, demonstrating strong "founder-market fit" is critical for early-stage fundraising. This often means deeply immersing oneself in patient and caregiver communities to understand their needs and challenges. - Investment in the longevity startup sector has seen a shift from large "moonshot" deals to more measured investments, with a focus on AI-powered drug discovery and preventative platforms. Global investment in longevity companies more than doubled to $8.49 billion in 2024, despite a slight decrease in the number of deals. - The rise of the "science founder," often a PhD with deep domain expertise stepping into a CEO role, is a defining characteristic of the longevity sector. However, finding executives with both scientific and entrepreneurial experience remains a challenge.
